How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

11,699 results for

Intrauterine Device

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

41. A prospective cohort study comparing expulsion after postplacental insertion: the levonorgestrel versus the copper intrauterine device. (PubMed)

A prospective cohort study comparing expulsion after postplacental insertion: the levonorgestrel versus the copper intrauterine device. To compare the expulsion rate at 6 months after postplacental insertion by intrauterine device (IUD) type.This prospective cohort included participants with a postplacental IUD inserted after vaginal or cesarean delivery, aged 18-45 and ≥24 weeks' gestation. Study enrollment took place after IUD selection and insertion. Participants returned for a postpartum (...) , 95% confidence interval 0.22-4.48).The expulsion rate at 6 months after postplacental insertion did not differ between the levonorgestrel and copper IUD type.Prior studies demonstrate a wide range of expulsion after postplacental insertion, and recent data suggest a higher expulsion rate for the levonorgestrel compared to the copper intrauterine device. However, many studies did not control for patient-level factors or delivery route. We found that when controlling for these confounding variables

2019 Contraception

42. Depot Medroxyprogesterone Acetate, Oral Contraceptive, Intrauterine Device Use, and Fracture Risk. (PubMed)

Depot Medroxyprogesterone Acetate, Oral Contraceptive, Intrauterine Device Use, and Fracture Risk. To assess fracture risk among women with depot medroxyprogesterone acetate (DMPA), oral contraceptive pill (OCP), and intrauterine device (IUD) use.A retrospective cohort study of 308,876 women age 12-45 years who initiated DMPA, combined or progestin-only OCPs, and copper and levonorgestrel IUDs from 2005 to 2015. Cumulative DMPA, OCP, and IUD use was assessed. Time since last DMPA injection

2019 Obstetrics and Gynecology

43. Intrauterine Device Use and Ovarian Cancer Risk: A Systematic Review and Meta-analysis. (PubMed)

Intrauterine Device Use and Ovarian Cancer Risk: A Systematic Review and Meta-analysis. To explore the relationship between intrauterine device (IUD) use and risk of ovarian cancer through systematic review of the literature and meta-analysis.We searched MEDLINE, EMBASE, Cochrane Library, Web of Science Core Collection from inception to June 2018. For the MEDLINE search, we included the MeSH terms "intrauterine devices" AND "ovarian neoplasms," however also searching "intrauter*," "ovar (...) to be 0.68 (95% CI 0.62-0.75). There were no significant differences found between covariates. Heterogeneity among all studies was found to be I=68%.Intrauterine device use is associated with a reduced incidence of ovarian cancer based on a review of existing retrospective data. Unfortunately, prospective investigation into the role of IUDs in ovarian cancer prevention is limited.

2019 Obstetrics and Gynecology

44. Use of Intrauterine Devices and Risk of HIV Acquisition among Insured Women in the U.S. (PubMed)

Use of Intrauterine Devices and Risk of HIV Acquisition among Insured Women in the U.S. Concerns have been raised about progestin-containing contraceptives and risk of HIV acquisition. Based on health insurance data from 622,565 women in the U.S. with intrauterine device (IUD) insertions during 2011-2018, there was no increased risk of incident HIV diagnosis among women using levonorgestrel-releasing IUDs compared with those using copper IUDs.© The Author(s) 2019. Published by Oxford University

2019 Clinical Infectious Diseases

45. Intrauterine Device Insertion Procedure Duration in Adolescent and Young Adult Women. (PubMed)

Intrauterine Device Insertion Procedure Duration in Adolescent and Young Adult Women. Intrauterine device (IUD) utilization in the United States is low among adolescent and young adult women. Longer procedure duration has been proposed as one potential barrier to IUD insertion in this population. We hypothesized that procedure duration would be longer in adolescents compared to young adult women.This study was a secondary analysis of a randomized clinical trial comparing the effectiveness

2019 Journal of pediatric and adolescent gynecology Controlled trial quality: uncertain

46. Paracervical Block for Intrauterine Device Placement Among Nulliparous Women: A Randomized Controlled Trial. (PubMed)

Paracervical Block for Intrauterine Device Placement Among Nulliparous Women: A Randomized Controlled Trial. 30575660 2018 12 21 1873-233X 133 1 2019 Jan Obstetrics and gynecology Obstet Gynecol Paracervical Block for Intrauterine Device Placement Among Nulliparous Women: A Randomized Controlled Trial. 189 10.1097/AOG.0000000000003043 Levine Elliot M EM Department of Obstetrics and Gynecology, Advocate Aurora Health Illinois Masonic Medical Center, Chicago, Illinois. Fernandez Carlos M CM eng

2019 Obstetrics and Gynecology Controlled trial quality: predicted high

47. Reducing Pain During Intrauterine Device Insertion: A Randomized Controlled Trial in Adolescents and Young Women

Reducing Pain During Intrauterine Device Insertion: A Randomized Controlled Trial in Adolescents and Young Women To estimate the effect of a 1% lidocaine paracervical nerve block on pain during intrauterine device (IUD) insertion compared with a sham block in adolescents and young women.We conducted a multisite, single-blind, sham-controlled randomized trial in adolescents and young women having a 13.5-mg levonorgestrel IUD inserted. Enrollment occurred at three family planning clinics

2017 EvidenceUpdates

48. A 1-year comparison of TCu380Ag versus TCu380A intrauterine contraceptive devices in India. (PubMed)

A 1-year comparison of TCu380Ag versus TCu380A intrauterine contraceptive devices in India. To compare TCu380Ag and TCu380A intrauterine contraceptive devices after 1 year of use.A prospective randomized controlled trial was conducted among healthy married women aged 20-35 years who attended the family planning clinics of three tertiary centers in India between August 1, 2015, to March 31, 2018. The TCu380Ag group (n=300) received one of three sizes of this device depending on uterocervical

2019 International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics Controlled trial quality: predicted high

49. New developments in intrauterine device use: focus on the US (PubMed)

New developments in intrauterine device use: focus on the US Many more women in the US today rely upon intrauterine devices (IUDs) than in the past. This increased utilization may have substantially contributed to the decline in the percentage of unintended pregnancies in the US. Evidence-based practices have increased the number of women who are medically eligible for IUDs and have enabled more rapid access to the methods. Many women enjoy freedom to use IUDs without cost, but for many

Full Text available with Trip Pro

2016 Open access journal of contraception

50. Intrauterine devices and risk of uterine perforation: current perspectives (PubMed)

Intrauterine devices and risk of uterine perforation: current perspectives Uterine perforation is an uncommon complication of intrauterine device insertion, with an incidence of one in 1,000 insertions. Perforation may be complete, with the device totally in the abdominal cavity, or partial, with the device to varying degrees within the uterine wall. Some studies show a positive association between lactation and perforation, but a causal relationship has not been established. Very rarely (...) , a device may perforate into bowel or the urinary tract. Perforated intrauterine devices can generally be removed successfully at laparoscopy.

Full Text available with Trip Pro

2016 Open access journal of contraception

51. Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy

Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy - ACOG Menu ▼ Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy Page Navigation ▼ Number 642, October 2015 (Replaces Committee Opinion Number 450, December 2009) (Reaffirmed 2018) Committee on Gynecologic Practice Long-Acting Reversible (...) Contraception Working Group This document reflects emerging clinical and scientific advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy ABSTRACT: Unintended pregnancy persists as a major public health problem in the United States. Although lowering unintended pregnancy rates requires

2015 American College of Obstetricians and Gynecologists

52. Small-sized ‘gold standard’ copper intrauterine devices may have lower discontinuation and fewer side effects than standard-sized counterparts

Small-sized ‘gold standard’ copper intrauterine devices may have lower discontinuation and fewer side effects than standard-sized counterparts Small-sized ‘gold standard’ copper intrauterine devices may have lower discontinuation and fewer side effects than standard-sized counterparts | BMJ Sexual & Reproductive Health blog by By Hannat Akintomide Pain and bleeding are the commonest unwanted effects of copper intrauterine contraception and pose barriers to continued use. When choosing copper (...) intrauterine contraception, the Faculty of Sexual and Reproductive Healthcare recommends a ‘gold standard’ intrauterine device (IUD). Gold standard IUDs are the most efficacious and have the longest duration of use. They contain at least 380mm 2 of copper and have banded copper on the arms. The most popular gold standard IUDs are the TT 380 Slimline® ( arm width 32 mm, stem length ≥33.6 mm) and the T-safe 380A® and T-safe 380A QL® ( 32 mm x 35.95 mm), each licensed for 10 years of use. The Mini TT 380

2019 Journal of Family Planning and Reproductive Health Care blog

53. Hysteroscopic removal of intrauterine devices in pregnancy. (PubMed)

Hysteroscopic removal of intrauterine devices in pregnancy. To introduce and demonstrate an approach to the hysteroscopic removal of retained intrauterine devices (IUDs) in pregnancy. Pregnancy risks associated with retained IUDs are also discussed, specifically spontaneous abortion and preterm labor.A step-by-step explanation of the procedure with surgical video footage.Academic medical center.We present four patients undergoing hysteroscopic removal of IUDs in pregnancy. All patients have

2018 Fertility and Sterility

54. Use of Copper Intrauterine Device in Transgender Male Adolescents. (PubMed)

Use of Copper Intrauterine Device in Transgender Male Adolescents. Transgender men need contraception if engaging in intercourse with a cis-gender male partner. The copper IUD is an effective, non-hormonal contraceptive well suited for trans-males even while utilizing gender affirming hormone therapy. A gender-neutral medical facility with well-trained and sensitive staff is the ideal setting to provide such contraceptive care.Copyright © 2018. Published by Elsevier Inc.

2018 Contraception

55. Recent Intrauterine device use and the risk of precancerous cervical lesions and cervical cancer. (PubMed)

Recent Intrauterine device use and the risk of precancerous cervical lesions and cervical cancer. Understanding the effect of contraceptives on the development of precancerous lesions of the cervix and cervical cancer may provide information that is valuable to women in contraceptive decision-making. The purpose of this study was to evaluate the association between recent intrauterine device (IUD) use (by type) and cervical intraepithelial neoplasia 2, 3, adenocarcinoma in situ or cancer (CIN2

2018 Contraception

56. Impact of training level on Postplacental Levonorgestrel 52mg intrauterine device expulsion. (PubMed)

Impact of training level on Postplacental Levonorgestrel 52mg intrauterine device expulsion. To determine the association between provider training level and postplacental intrauterine device (IUD) outcomes following insertion instruction by email only.We conducted a single-center chart review of demographics, insertion and clinical outcomes within 6 months of delivery for 116 patients who underwent postplacental levonorgestrel 52 mg IUD placement from October 1, 2016, to March 31, 2017.We

2018 Contraception

57. Intraoperative ultrasound assistance for the surgical removal of lost intrauterine device. (PubMed)

Intraoperative ultrasound assistance for the surgical removal of lost intrauterine device. A 45-year woman, carrying an IUD for 2 years, was referred to our emergency unit for pelvic pain and bleeding. At vaginal examination, the strings of the IUD were not identified. Laboratory parameters were unremarkable. The abdominal radiography documented the presence of IUD in the abdominal cavity (FIG.1). During laparoscopy, the surgeon was unable to localize the IUD and an intraoperative ultrasound

2018 Ultrasound in Obstetrics and Gynecology

58. Effect of a novel copper-containing intrauterine device material on the endometrial environment in rabbits. (PubMed)

Effect of a novel copper-containing intrauterine device material on the endometrial environment in rabbits. This study aimed to determine whether intrauterine placement of a novel composite material [copper (Cu) microparticles, low-density polyethylene, and methyl vinyl silicone rubber (Cu/LDPE/MVQ)] could prevent pregnancy in rabbits, and to evaluate the effects of Cu/LDPE/MVQ on the endometrial environment.Eighty sexually mature female rabbits were randomly divided into four groups (n=20 each (...) Cu-containing intrauterine device material exhibits a similar effect in prevention of pregnancy with bare copper, and lower levels of inflammatory markers.This study demonstrates the potential of the novel Cu/LDPE/MVQ microcomposite material as a future substitute for conventional intrauterine device materials.Copyright © 2018 Elsevier Inc. All rights reserved.

2018 Contraception

59. Intrauterine Device Insertion Before and After Mandated Health Care Coverage: The Importance of Baseline Costs. (PubMed)

Intrauterine Device Insertion Before and After Mandated Health Care Coverage: The Importance of Baseline Costs. To evaluate changes in out-of-pocket cost for intrauterine device (IUD) placement before and after mandated coverage of contraceptive services and to examine how changes in out-of-pocket cost influence IUD insertion as a function of baseline cost.We conducted a cross-sectional pre-post analysis at the plan level using a large deidentified medical claims database to analyze our primary

2018 Obstetrics and Gynecology

60. Six-month expulsion of postplacental copper intrauterine devices placed after vaginal delivery. (PubMed)

Six-month expulsion of postplacental copper intrauterine devices placed after vaginal delivery. Immediate placement of an intrauterine device after vaginal delivery is safe and convenient, but longitudinal data describing clinical outcomes have been limited.We sought to determine the proportion of TCu380A (copper) intrauterine devices expelled, partially expelled, malpositioned, and retained, as well as contraceptive use by 6 months postpartum, and determine risk factors for expulsion (...) and partial expulsion.In this prospective, observational study, women who received a postplacental TCu380A intrauterine device at vaginal delivery were enrolled postpartum. Participants returned for clinical follow-up at 6 weeks, and for a research visit with a pelvic exam and ultrasound at 6 months. We recorded intrauterine device outcomes and 6-month contraceptive use. Partial expulsion was defined as an intrauterine device protruding from the external cervical os, or a transvaginal ultrasound showing

2018 American Journal of Obstetrics and Gynecology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>